BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26985905)

  • 21. DAG accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells.
    Montell E; Turini M; Marotta M; Roberts M; Noé V; Ciudad CJ; Macé K; Gómez-Foix AM
    Am J Physiol Endocrinol Metab; 2001 Feb; 280(2):E229-37. PubMed ID: 11158925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterisation of fatty acid metabolism in different insulin-resistant phenotypes by means of stable isotopes.
    Blaak EE
    Proc Nutr Soc; 2017 Jan; ():1-7. PubMed ID: 28100287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired glucose tolerance is a more advanced stage of alteration in the glucose metabolism than impaired fasting glucose.
    Guerrero-Romero F; Rodríguez-Morán M
    J Diabetes Complications; 2001; 15(1):34-7. PubMed ID: 11259924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mild fasting hyperglycemia shifts fuel reliance toward fat during exercise in adults with impaired glucose tolerance.
    Malin SK; Viskochil R; Oliver C; Braun B
    J Appl Physiol (1985); 2013 Jul; 115(1):78-83. PubMed ID: 23599396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
    Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin sensitivity and metabolic flexibility following exercise training among different obese insulin-resistant phenotypes.
    Malin SK; Haus JM; Solomon TP; Blaszczak A; Kashyap SR; Kirwan JP
    Am J Physiol Endocrinol Metab; 2013 Nov; 305(10):E1292-8. PubMed ID: 24064339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of the CD36 gene with impaired glucose tolerance, impaired fasting glucose, type-2 diabetes, and lipid metabolism in essential hypertensive patients.
    Wang Y; Zhou XO; Zhang Y; Gao PJ; Zhu DL
    Genet Mol Res; 2012 Aug; 11(3):2163-70. PubMed ID: 22869067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content.
    Bruce CR; Thrush AB; Mertz VA; Bezaire V; Chabowski A; Heigenhauser GJ; Dyck DJ
    Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E99-E107. PubMed ID: 16464906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum lipid and hsCRP levels in prediabetes--impaired fasting glucose (IFG) and impaired glucose tolerance (IGT).
    Chakarova N; Tankova T; Atanassova I; Dakovska L
    Diabetes Res Clin Pract; 2009 Oct; 86(1):56-60. PubMed ID: 19674805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of skeletal muscle-fibre type in regulation of glucose metabolism in middle-aged subjects with impaired glucose tolerance during a long-term exercise and dietary intervention.
    Venojärvi M; Puhke R; Hämäläinen H; Marniemi J; Rastas M; Rusko H; Nuutila P; Hänninen O; Aunola S
    Diabetes Obes Metab; 2005 Nov; 7(6):745-54. PubMed ID: 16219019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postprandial interleukin-6 release from skeletal muscle in men with impaired glucose tolerance can be reduced by weight loss.
    Corpeleijn E; Saris WH; Jansen EH; Roekaerts PM; Feskens EJ; Blaak EE
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5819-24. PubMed ID: 16030153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased intramuscular lipid synthesis and low saturation relate to insulin sensitivity in endurance-trained athletes.
    Bergman BC; Perreault L; Hunerdosse DM; Koehler MC; Samek AM; Eckel RH
    J Appl Physiol (1985); 2010 May; 108(5):1134-41. PubMed ID: 20299618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1.
    Koopmans SJ; Jong MC; Que I; Dahlmans VE; Pijl H; Radder JK; Frölich M; Havekes LM
    Diabetologia; 2001 Apr; 44(4):437-43. PubMed ID: 11357474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial dysfunction and inhibition of myoblast differentiation in mice with high-fat-diet-induced pre-diabetes.
    Xu D; Jiang Z; Sun Z; Wang L; Zhao G; Hassan HM; Fan S; Zhou W; Han S; Zhang L; Wang T
    J Cell Physiol; 2019 May; 234(5):7510-7523. PubMed ID: 30362548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intramyocellular lipids form an important substrate source during moderate intensity exercise in endurance-trained males in a fasted state.
    van Loon LJ; Koopman R; Stegen JH; Wagenmakers AJ; Keizer HA; Saris WH
    J Physiol; 2003 Dec; 553(Pt 2):611-25. PubMed ID: 14514877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status.
    Bruce CR; Anderson MJ; Carey AL; Newman DG; Bonen A; Kriketos AD; Cooney GJ; Hawley JA
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5444-51. PubMed ID: 14602787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin acutely upregulates protein expression of the fatty acid transporter CD36 in human skeletal muscle in vivo.
    Corpeleijn E; Pelsers MM; Soenen S; Mensink M; Bouwman FG; Kooi ME; Saris WH; Glatz JF; Blaak EE
    J Physiol Pharmacol; 2008 Mar; 59(1):77-83. PubMed ID: 18441389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperinsulinemia and skeletal muscle fatty acid trafficking.
    Kanaley JA; Shadid S; Sheehan MT; Guo Z; Jensen MD
    Am J Physiol Endocrinol Metab; 2013 Aug; 305(4):E540-8. PubMed ID: 23820622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes.
    Storgaard H; Jensen CB; Björnholm M; Song XM; Madsbad S; Zierath JR; Vaag AA
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1301-11. PubMed ID: 15001626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resveratrol prevents insulin resistance caused by short-term elevation of free fatty acids in vivo.
    Pereira S; Park E; Moore J; Faubert B; Breen DM; Oprescu AI; Nahle A; Kwan D; Giacca A; Tsiani E
    Appl Physiol Nutr Metab; 2015 Nov; 40(11):1129-36. PubMed ID: 26455923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.